This issue includes six articles that develop and apply statistical methods for the analysis of gene sequencing data of different types. The methods are tailored to the different data types and, in each case, lead to biological insights not readily identified without the use of statistical methods. A common feature in all articles is the development of methods for analyzing simultaneously data of different types (e.g., genotype, phenotype, pedigree, etc.); that is, using data of one type to inform the analysis of data from another type.
This is an electronic reprint of the original article published by the Institute of Mathematical Statistics in The Annals of Applied Statistics, 2012, Vol. 6, No. 2, 429-431 . This reprint differs from the original in pagination and typographic detail. 1 2 K. KAFADAR negative effects of errors in sequence reads and alignments and hence enable better inference. The approach is applied to data from both simulations and the "1000 Genomes Project" and is shown to improve the estimates of model parameters and hence the accuracy of genotype calling. Shen and Zhang develop a change-point model based on a nonhomogeneous Poisson process (NHPP) to model sequence-read data on DNA copy number variants (CNVs) in normal (reference) samples, versus copy number aberrations (CNAs) in treated (target) samples. Regions of intensity shifts in the NHPP may signal regions of genetic polymorphisms that may be related to the differences between target and reference samples. Using a generalized likelihood ratio statistic and a modified Bayes information criterion to select the appropriate number of change-points, Shen and Zhang construct Bayesian point-wise "credible intervals" to assess quantitatively the effects of meaningful copy number estimates. The high-throughput nature of sequencing data necessitates computationally efficient algorithms which are applied to sequencing data from tumor and normal cell lines.
Zhou et al. also develop an approach to the analysis of multiple gene expression studies which were conducted to identify differentially expressed (DE) genes. In their article, the authors use Bayesian model averaging (BMA) with empirically-based prior model probabilities; simulations demonstrate improved performance (sensitivity, specificity) of DE gene detection using BMA versus one-at-a-time single-model approaches. Applied to two microarray data sets, the results identify DE genes related to lung disease with covariates (smoking status, gender, race) than found by either data set alone.
With multiple lists of apparently "significantly" differentially expressed genes, Natarajan et al. describe approaches to quantify the "significance" of top-ranked genes that appear to be influential in several studies. Given N studies, in each of which the effects of T genes are studied and ranked, in how many of those N studies would we expect n of the r top-ranked genes to appear? Natarajan et al. use the Poisson distribution, expected sensitivity, and false discovery rate (FDR) to characterize the significance of the size of the set of frequently-appearing genes in the N studies and illustrate their inference method on studies on prostate cancer gene expression.
In the final article of this special section, Telesca et al. take a Bayesian approach to characterize dependence among genes, and use directed graphs to account for this dependence to explore, and develop inferences about, differences in dependencies among genes. The approach is motivated by a search for genes related to specific pathways that have been identified in the progression of ovarian cancer.
High-throughput or next generation sequencing data, with their high levels of sample dependence, size, and dimension, present challenges to conventional statistical methods that typically assume independence and "n > p"
